Aetna Better Health of Illinois, Mae Health to give access to doulas, postpartum health supportThe partnership between Mae and Aetna aims to reduce the disproportionate pregnancy-related deaths and complications among those at highest risk. Amneal moves to NasdaqThe Nasdaq move will be effective on Dec. 27, 2023. FDA approves expanded use of Astella's Cresemba Cresemba is the only azole antifungal therapy approved for pediatric patients affected by these serious, potentially life-threatening infections. Alembic rolls out generic Aczone Dapsone Gel is a sulfone indicated for the topical treatment of acne vulgaris in patients aged 9 years old and older. Long Grove partners with Sunny Pharmtech to launch cyclophosphamide for injection Cyclophosphamide for Injection is an antineoplastic chemotherapy medication that slows the growth of cancer cells. A new environment for biosimilars As demand continues to grow, biologics’ impact on rising medical costs needs to be considered. Dr. Reddy’s debuts on Dow Jones Sustainability World Index The company retains its place in the Dow Jones Sustainability Index for Emerging Markets for an eighth year in a row. Kroger taps Better Health Group for senior-focused primary care at The Little Clinic Better Health Group's comprehensive MSO platform will help providers at The Little Clinic manage the primary healthcare needs of seniors with Medicare. OneroRx acquires 3 specialty pharmacies The three pharmacies acquired are Juniper Pharmacy in St. Louis; Lee’s Summit Pharmacy in Lee’s Summit, Mo.; and Willowbrook Pharmacy in Carmel, Ind. Amneal, BIAL ink U.S. licensing agreement for Ongentys Ongentys (opicapone) is an adjunctive therapy for the treatment of Parkinson’s disease. First Previous 110 111 112 113 114 Next Last
